Artículos científicos Open Access
Ongoing asthma management in children during the COVID-19 pandemic: to step down or not to step down?
Elissa Michele Abrams, Stanley Szefler
The Lancet Respiratory Medicine
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial
Timothy S C Hinks, et al
The Lancet Respiratory Medicine
Azithromycin: can its benefit be ruled out in mild COVID-19?
Alejandro Rodríguez-Molinero
The Lancet Respiratory Medicine
Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study
Waasila Jassat, et al
The Lancet Global Health
Lessons from two SARS-CoV-2 waves in South Africa
Linda-Gail Bekker, Ntobeko A B Ntusi
The Lancet Global Health
Genomics-informed responses in the elimination of COVID-19 in Victoria, Australia: an observational, genomic epidemiological study
Courtney R Lane, et al
The Lancet Public Health
ROCCA observational study: Early results on safety of Sputnik V vaccine (Gam-COVID-Vac) in the Republic of San Marino using active surveillance
Marco Montalti, et al
EClinicalMedicine
The effect of methotrexate and targeted immunosuppression on humoral and cellular immune responses to the COVID-19 vaccine BNT162b2: a cohort study
Satveer K Mahil, et al
The Lancet Rheumatology
Impact of methotrexate on first-dose COVID-19 mRNA vaccination
Caoilfhionn M Connolly, Julie J Paik
The Lancet Rheumatology
Decreased infectivity following BNT162b2 vaccination: A prospective cohort study in Israel
Gili Regev-Yochay, et al
The Lancet Regional Health – Europe
Mass infection is not an option: we must do more to protect our young
Deepti Gurdasani, et al
The Lancet
